Tag: high-risk
The Sad Pragmatism of Inflation-Era Cuisine
This is an edition of Up for Debate, a newsletter by Conor Friedersdorf. On Wednesdays, he rounds up timely conversations and solicits reader responses to one thought-provoking question. Later, he publishes some thoughtful replies. Sign up for the newsletter here.
Question of the Week
What are your best tips––at this time of rapidly rising prices––for cutting costs in ways that meet your needs while depriving you of as little pleasure or convenience or comfort as possible? OR, looking back on
Biden’s COVID Is Back. Is Paxlovid to Blame?
Four days after recovering from a COVID-19 infection, President Joe Biden has tested positive again. When he first got sick, Biden—like more than one-third of the Americans who have tested positive for COVID-19 this summer, according to the U.S. government’s public records—was prescribed Paxlovid, an antiviral pill treatment made by Pfizer. Like many Paxlovid takers, he soon tested negative and resumed his normal activities. And then, like many Paxlovid takers, his infection came right back. (Biden does not currently have
The Missing Part of America’s Pandemic Response
Many parts of the U.S. government, including its leading scientific agencies, are being blamed for the country’s chaotic and disorganized response to COVID-19. The CDC’s muddled and mistaken messaging about masks, testing, and the mechanism of viral spread sowed public confusion. The FDA’s extreme caution about approving boosters may have slowed the deployment of those vital measures. But a nation’s ability to weather a pandemic also depends upon its underlying ability to make major scientific discoveries, even—or especially—during moments of
A Stress Test for America’s New COVID Plan Is Coming
At this very moment, the United States, as a whole, remains in its legit pandemic lull. Coronavirus case counts and hospitalizations are lower than they’ve been since last summer. There’s now a nice, chonky gap between us and January’s Omicron peak.
And yet. Outbreaks have erupted across Asia. Massive swaths of Europe, including the United Kingdom—America’s best pandemic bellwether for much of 2021—are firmly in the grip of a more transmissible Omicron subvariant called BA.2 that’s been simmering stateside for
The CDC Shifted the Pandemic’s Burden to the Vulnerable
This time last week, nearly all Americans were still being urged by the nation’s leadership to please, keep those darn masks on. Then the Great American Unmasking Part Deux began. On Friday, the CDC debuted a new set of COVID-19 guidelines that green-lit roughly 70 percent of us—effectively, anyone living in a place where hospitals are not being actively overrun by the coronavirus—to doff our masks in most indoor public settings. The stamina of mask policy had been flagging for
COVID Risk Factors Could Be Hiding In Our Genes
On the surface, the September 24 announcement from the head of the CDC outlining who, exactly, would be eligible for COVID-19 booster shots seemed like a clarifying moment. But even as the agency’s leader, Rochelle Walensky, declared the need to make “concrete recommendations that optimize health,” the new guidance was hard to parse. It said, for instance, that people as young as age 18 who received the Pfizer vaccine may get a third shot as long as they have any
The Lab-Leak Debate Just Got Even Messier
As the pandemic drags on into a bleak and indeterminate future, so does the question of its origins. The consensus view from 2020, that SARS-CoV-2 emerged naturally, through a jump from bats to humans (maybe with another animal between) persists unchanged. But suspicions that the outbreak started from a laboratory accident remain, shall we say, endemic. For months now, a steady drip of revelations have sustained an atmosphere of profound unease.
The latest piece of evidence came out this